huperzine a
Huperzine A is a natural compound extracted from Chinese club moss that inhibits acetylcholinesterase, increasing acetylcholine levels in the brain. It enhances memory, learning, and may have neuroprotective properties.
Lab Notes — Research Studies
01 Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease
Reviews how Huperzine A, an alkaloid from club moss, interacts with molecular pathways including Wnt signaling, synaptic mechanisms, and amyloid-β accumulation to provide neuroprotection.
View Study ((PubMed))02 Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
Highlights positive outcomes from plant-based therapies including Huperzine A in improving cognitive function and neuropsychiatric symptoms in Alzheimer's patients.
View Study ((PubMed))03 Delineating biosynthesis of Huperzine A, A plant-derived medicine for the treatment of Alzheimer's disease
Explores alternative production methods for Huperzine A, including biosynthesis and pathway engineering, to address supply constraints from slow-growing plant sources.
View Study ((PubMed))04 Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models
Animal studies demonstrate Huperzine A's potential to improve memory and reduce harmful brain substances, though findings require further confirmation.
View Study ((PubMed))05 The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews
Meta-analysis finding Huperzine A may benefit Alzheimer's patients with cognitive function but lacks sufficient evidence for other cognitive impairments.
View Study ((PubMed))06 Neuroprotective effect of huperzine-A against cadmium chloride-induced Huntington's disease in Drosophila melanogaster model
Laboratory studies suggest Huperzine A reduces neurodegenerative symptoms in cell and fly models, indicating promise for Huntington's disease.
View Study ((ScienceDirect))07 Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease
Injectable Huperzine A improved motor and cognitive function in mice with Parkinson's disease by reducing inflammation and oxidative stress.
View Study ((ScienceDirect))Formula — Benefits & Dosage
⚗️ Effects
- Potent AChE Inhibitor: More selective than donepezil.
- Long-Lasting: Effects persist due to long half-life.
- Synergy: Works well with choline sources.
💉 Dosage & Administration
- Typical Range: 50-200mcg once or twice daily.
- Cycling: Recommended due to long half-life (cycle 2-4 weeks on/off).
- Start Low: Begin with 50mcg to assess response.
⚠️ Side Effects
- Cholinergic Effects: Nausea, headache, muscle twitching possible.
- GI Issues: Digestive discomfort in some users.
- Accumulation: Can build up due to long half-life.
- Not with AChE Inhibitors: Avoid combining with donepezil or similar drugs.
📦 Availability & Sourcing
- Supplement: Available in most nootropic and supplement stores.
- Various Forms: Capsules, tablets, and powder.
- Affordable: Generally inexpensive.
Reaction Log — User Experiences
Users report improved memory and mental clarity. Popular in nootropic stacks, particularly for cholinergic enhancement. Long half-life requires careful dosing.
Synthesis — Related Compounds
⚠️ IMPORTANT DISCLAIMER
This information is for educational and research purposes only. huperzine a may not be approved for human use. Always consult a qualified healthcare professional before using any supplements or research compounds. We do not guarantee accuracy or completeness of information presented.